KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Capital Employed (2016 - 2025)

Eli Lilly (LLY) has disclosed Return on Capital Employed for 16 consecutive years, with 0.37% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 4.0% year-over-year to 0.37%, compared with a TTM value of 0.37% through Dec 2025, up 4.0%, and an annual FY2025 reading of 0.48%, up 11.0% over the prior year.
  • Return on Capital Employed was 0.37% for Q4 2025 at Eli Lilly, down from 0.38% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.39% in Q2 2025 and bottomed at 0.19% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.28%, with a median of 0.27% recorded in 2023.
  • The sharpest move saw Return on Capital Employed fell -6bps in 2023, then grew 10bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.22% in 2021, then rose by 17bps to 0.26% in 2022, then rose by 19bps to 0.3% in 2023, then grew by 9bps to 0.33% in 2024, then rose by 12bps to 0.37% in 2025.
  • Business Quant data shows Return on Capital Employed for LLY at 0.37% in Q4 2025, 0.38% in Q3 2025, and 0.39% in Q2 2025.